New Advances in General Biomedical Applications of PAMAM Dendrimers
AbstractDendrimers are nanoscopic compounds, which are monodispersed, and they are generally considered as homogeneous. PAMAM (polyamidoamine) was introduced in 1985, by Donald A. Tomalia, as a new class of polymers, named ‘starburst polymers’. This important contribution of Professor Tomalia opened a new research field involving nanotechnological approaches. From then on, many groups have been using PAMAM for diverse applications in many areas, including biomedical applications. The possibility of either linking drugs and bioactive compounds, or entrapping them into the dendrimer frame can improve many relevant biological properties, such as bioavailability, solubility, and selectivity. Directing groups to reach selective delivery in a specific organ is one of the advanced applications of PAMAM. In this review, structural and safety aspects of PAMAM and its derivatives are discussed, and some relevant applications are briefly presented. Emphasis has been given to gene delivery and targeting drugs, as advanced delivery systems using PAMAM and an incentive for its use on neglected diseases are briefly mentioned. View Full-Text
Share & Cite This Article
Araújo, R.V.; Santos, S.S.; Igne Ferreira, E.; Giarolla, J. New Advances in General Biomedical Applications of PAMAM Dendrimers. Molecules 2018, 23, 2849.
Araújo RV, Santos SS, Igne Ferreira E, Giarolla J. New Advances in General Biomedical Applications of PAMAM Dendrimers. Molecules. 2018; 23(11):2849.Chicago/Turabian Style
Araújo, Renan V.; Santos, Soraya S.; Igne Ferreira, Elizabeth; Giarolla, Jeanine. 2018. "New Advances in General Biomedical Applications of PAMAM Dendrimers." Molecules 23, no. 11: 2849.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.